The global bisphosphonate drug market is anticipated to grow at a CAGR of nearly 4.5% during the forecast period (2022-2028). Bisphosphonates belong to the class of drugs that prevent the bone mineralization or resorption by stopping the action of osteoclasts. Bisphosphonates are enzyme-resistant analogues of pyrophosphate, which normally inhibits mineralization in the bone. Their effect is dose dependent and they reduce the turnover of bone by inhibiting recruitment and promoting apoptosis of osteoclasts. Bisphosphonates are used to treat postmenopausal and glucocorticoid induced osteoporosis, Paget’s disease of bone and malignant hypercalcemia. Osteoporosis is a chronic disease which results in the reduction of bone mass and bone density. The global bisphosphonate drug market is attributable to the growing prevalence of osteoporosis across the globe is the major driver for the growth of global osteoporosis market.
For instance, according to International Osteoporosis Foundation, Osteoporosis causes more than 8.9 million fractures annually, resulting in an osteoporotic fracture every 3 seconds and also it is estimated to affect 200 million women globally. In addition to this, the rising geriatric population aged above 50 years are at the greatest risk of developing osteoporosis and related fractures due to hormonal changes. So this rise in aging population also fueling the growth of global bisphosphonate drug market. Development of novel approaches for the treatment of osteoporosis by new drugs and increase in awareness among people for the early diagnosis & treatment are also some of the major factors for the growth of this market.
(Get 15% Discount on Buying this Report)
Get Sample Copy of bisphosphonate drug market at:
https://orionmarketreports.com/request-sample/?id=94090&submit=Request+Sample%0D%0A
Market Coverage
The market number available for – 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
Regions covered-
North America
Europe
Asia-Pacific
Rest of the World
Top major key players:
Merck & Co., Inc., Mylan NV, and Novartis International AG, among others.
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How are players addressing challenges to sustain growth?
Where is the investment opportunity?
A full report of bisphosphonate drug market is available at:
https://orionmarketreports.com/global-bisphosphonate-drug-market/94090/
Global Bisphosphonate Drug Market Report by Segment
By Type
Alendronate
Risedronate
Zoledronic Acid
Others
By Application
Post-Menopausal Osteoporosis
Bone Loss Caused by Cancer Treatment
Complex Regional Pain Syndrome’
Paget’s Disease
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
